Objective-Infusion of angiotensin II (Ang II) induces extracellular matrix remodeling and inflammation resulting in abdominal aortic aneurysms (AAAs) in normolipidemic mice. Although Ang II activates mesenchymal cells in the media and adventitia to become fibrogenic, the sentinel role of this mesenchymal population in modulating the inflammatory response and aneurysms is not known. We test the hypothesis that these fibrogenic mesenchymal cells play a critical role in Ang II-induced aortic wall vascular inflammation and AAA formation. Approach and Results-Ang II infusion increased phospho-Ser536-RelA and interleukin (IL)-6 immunostaining in the abdominal aorta. In addition, aortic mRNA transcripts of RelA-dependent cytokines IL-6 and IL-1β were significantly elevated suggesting that Ang II functionally activates RelA signaling. To test the role of mesenchymal RelA in AAA formation, we generated RelA-CKO mice by administering tamoxifen to double transgenic mice harboring RelA-flox alleles and tamoxifen-inducible Col1a2 promoter-driven Cre recombinase (Col1a2-CreER 
A bdominal aortic aneurysm (AAA) can be a fatal disease because of its propensity to cause aortic rupture. In the United States, the prevalence of AAA ranges from 1.3% in middle-aged men to 12.5% in men >70. 1 AAA is characterized by aortic lumen expansion, infiltration of leukocytes into the aortic media and adventitia, and extracellular matrix (ECM) degradation. 2 The angiotensin II (Ang II) infusion model has been widely used to study the pathogenesis of AAA-a disease that often is detected only in its later stages. Ang II infusion for 7 to 28 days into normolipidemic (C57Bl/6) or hyperlipidemic (LDLR−/− or ApoE−/−) mice leads to AAA formation. [3] [4] [5] The incidence of AAA increases by feeding a high-fat diet to C57Bl/6 mice, but the presence of hypercholesterolemia and adiposity complicates the interpretation of Ang II effects on the aortic wall. 5 Ang II infusion produces aortic aneurysms through a 2-hit process, producing stromal cell activation followed by ECM remodeling mediated by recruitment and local tissue differentiation of effector macrophages. 6, 7 Although the mechanisms controlling macrophage recruitment and activation in the later stages of AAA formation are relatively well understood, the primary cell type responding to Ang II is not. Ang II has potent effects on ECM remodeling-this process is mediated by activating mesenchymal cells, cells of heterogeneous lineage that secrete type I collagen composed of α1 and α2 peptides and encoded by Col1a1 and Col1a2, 8, 9 the transforming growth factor-β, 10 and activated matrix metalloproteinases. [11] [12] [13] These mesenchymal cells include adventitial fibroblasts, myofibroblasts, and subpopulations of Col1α-expressing synthetic vascular smooth muscle cells (VSMCs). Although ECM remodeling/ fibrosis and vascular inflammation are thought to be largely distinct processes, recent studies have shown that ECM remodeling has significant effects on the fibroblast-myofibroblast transition, activation of intercellular adhesion molecules, formation of chemotactic molecules from the processing of the α1 peptide, and regulation of leukocyte infiltration.
14 These data suggest the intriguing possibility that Ang II activation of mesenchymal cells with a fibrogenic phenotype in the aortic wall may be closely coupled to vascular inflammation and AAA formation.
After the initial trigger of mesenchymal cell activation, subsequent leukocyte activation is mediated by a coordinate secretion of chemotactic cytokines, upregulation of intercellular adhesion molecules and production of activating cytokines responsible for acquisition of effector cell functions, and ECM remodeling. These genes are controlled at the level of transcription by the nuclear factor-κB (NF-κB) transcription factor. Ang II is a potent inducer of NF-κB pathway activation. 6 In mesenchymal cells, Ang II activates the latent transcriptional potential of the NF-κB complex by phosphorylating the transcriptional subunit NF-κB/RelA on Ser 536 by the NF-κB-inducing kinase. 15, 16 In this manner, RelA induces transcription of interleukin (IL)-6, ICAM-1 (intercellular adhesion molecule-1), and VCAM-1 (vascular cell adhesion molecule-1). 15, 17 NF-κB is also required for priming expression of pro-IL-1β subsequently processed by the activation of the NLRP3 (NLR [nucleotide oligomerization domain-like receptor] family pyrin domain containing 3) inflammasome and involved in Ang II-induced AAA formation. 18, 19 Interestingly, our previous studies showed that IL-6 was secreted by mesenchymal-like fibroblasts 20, 21 -an activating cytokine that promotes macrophage activation and aortic dissections during Ang II infusion. 3, 20 Based on our previous findings that IL-6-a cytokine produced mostly by aortic adventitial fibroblasts-is a mediator of AAA formation and that RelA signaling is necessary for IL-6 transcription, we hypothesized that fibrogenic mesenchymal cells are a major trigger for Ang II-induced vascular inflammation and AAA. Knowing that the NF-κB/RelA pathway is the major intercellular signaling pathway responsible for the vascular inflammation, we generated RelA-CKO mice by administering tamoxifen to transgenic mice harboring a tamoxifen-inducible Col1a2-driven CreER (Col1a2-CreER T ) and RelA-floxed (RelA f/f) alleles. Knowing that Ang II-induced Col1A expression is mediated by a subpopulation of fibroblasts, smooth muscle actin (SMA) 22+ myofibroblasts, and synthetic phenotype VSMCs, we tested the role of fibrogenic mesenchymal NF-κB signaling on AngII-induced inflammation and dissections. To accomplish this, we bred tamoxifeninducible Col1a2-CreER T 22, 23 and RelA f/f mice, the latter containing loxP sites in intron 4 and intron 8 generated in our laboratory. 24 To verify the specificity of the Col1a2-CreER T , we also crossed the transgenic mouse harboring this Cre with mT/mG Cre-reporter mice. The cells of mT/mG mouse constitutively express membrane-targeted dTomato (mT) and switch expression to eGFP (enhanced green fluorescence protein; mG) after Cre-mediated excision of dTomato allele. 25 In addition, the mT/mG reporter allele is knocked into the ROSA26 locus allowing the allele to be ubiquitously expressed. Our data indicate that Col1a2-CreER T is activated in a subpopulation of mesenchymal cells, including fibroblasts and VSMCs, but not in endothelial cells. Deletion of mesenchymal RelA in in the RelA-CKO mice conferred protection from Ang II-induced AAA without affecting blood pressure. These studies directly implicate for the first time a central role of RelA activation in fibrogenic mesenchymal cells in the development of Ang II-induced vascular inflammation and AAA.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Ang II Infusion Increased RelA Signaling in the Aortic Wall
Ang II is a potent inducer of RelA-dependent cytokine IL-6 in vivo and in vitro. 6 Furthermore, Ang II infusion into rats has been demonstrated to increase total aortic phospho-Ser536-RelA as measured by an ELISA assay. 15 To determine which aortic cells have increased RelA signaling during Ang II infusion, we infused 3 wild-type (WT) C57BL/6 mice with saline (sham) and 4 WT mice with Ang II for 7 days before isolating their aortas for immunohistochemistry and quantitative reverse transcriptase-polymerase chain reaction analysis. Although no animals developed an aortic aneurysm during the 1-week period, analysis of suprarenal abdominal aortas indicated a dramatic increase in phospho-Ser536 RelA staining in aortas from Ang II-infused mice, demonstrating that Ang II potently induced RelA signaling in the aortic wall in vivo ( Figure 1A ; controls are in Figure I in the online-only Data Supplement). Phospho-Ser536 RelA staining was observed throughout the media and the expanded adventitia suggesting that Ang II activates RelA signaling in multiple cell types. Because IL-6 is a downstream target of phospho-Ser536 RelA, we performed immunofluorescence analysis for IL-6 in both groups. There was slight positive immunostaining for IL-6 in aortas from the sham group, but increased immunostaining was observed in the media and the adventitia in aortas from the Ang II group. These data sets complement each other and support the conclusion that Ang II activates phospho-Ser536 RelA and its pathway in medial and adventitial cells of the abdominal aorta.
VSMCs populate the media and express high levels of smooth muscle cell α-actin (αSMA), and immunofluorescence detection of αSMA via confocal microscopy verified that medial cells were αSMA+ ( Figure 1B ). In addition, there was almost complete absence of αSMA signal in the adventitia, with few cells expressing a signal above background levels. Although this suggests the majority of medial cells were αSMA+VSMCs, myofibroblasts are also known to express αSMA and may be present in the medial and adventitial layers. Platelet-derived growth factor receptor α (PDGFRα) is found on Col1a1-expressing cells in the myocardium and has been reported to be a reliable marker for cardiac fibroblasts. 26 However, immunofluorescent detection of PDGFRα in the aortic wall indicated its presence on cells in the media and adventitia ( Figure 1B ), indicating this marker has no specificity for aortic adventitial fibroblasts and may be a more general mesenchymal marker in the aorta.
To determine whether Ang II-induced functional RelA activity, expression of the NF-κB-dependent chemokines/cytokines IL-1β, MCP-1 (monocyte chemoattractant protein-1), and IL-33 was measured by quantitative reverse transcriptasepolymerase chain reaction analysis on aortas from sham and Ang II groups ( Figure 1C ; Table I in the online-only Data Supplement). Ang II infusion increased IL-6 transcripts 16-fold and IL-1β transcripts 25-fold. Furthermore, IL-33-a member of IL-1 family of cytokines-was increased 2-fold. Although the chemokine MCP-1 was slightly elevated in aortas from the Ang II group (1.8-fold versus sham), the difference was not significant. Elevation of IL-6, IL-1β, and IL-33 transcripts validates our immunohistochemistry experiments and verifies that Ang II infusion stimulates RelA signaling in the aortic wall.
Col1a2-CreER T Is Activated by Tamoxifen in Aortic Mesenchymal Cells
To test the role of mesenchymal RelA in aortic inflammation and AAA, we used Col1a2-CreER T transgenic mice in which tamoxifen administration was previously demonstrated to activate CreER T recombinase in fibrogenic mesenchymal cells (vascular fibroblasts and VSMCs). In addition to crossing the Col1α2-CreER T mouse with a RelA f/f, we also crossed the CreER T transgenic with the mT/mG Cre-reporter mouse. 25 In mice harboring the mT/mG alleles, activation of CreER T with tamoxifen leads to excision of the dTomato allele and expression of eGFP. We subjected mT/mG•CreER Arrows indicate positive immunostaining in the media and adventitia. IL-6 was detected using AF-568-conjugated secondary antibody. Images were captured at a ×400 magnification. B, Aortic cross-sections were immunostained for α-smooth muscle actin (αSMA)-a smooth muscle cell contractile protein-and PDGFRα (platelet-derived growth factor receptor α)-a marker associated with fibroblasts. Images were captured at a ×630 magnification using a confocal microscope. L, vascular lumen. C, Quantitative reverse transcriptase-polymerase chain reaction was performed on aortas from sham and Ang II group to detect changes in RelA-dependent cytokine/chemokine expression. Data are presented as mean±SEM. *P<0.05; #P=0.055 vs sham.
of eGFP expression. This verified that our 10-day tamoxifen dosing regimen stimulates Col1a2-CreER T activation and also demonstrated that Col1a2-CreER T is activated in mesenchymal cells of the aortic media and adventitia.
To identify cells that underwent genetic recombination after tamoxifen administration, dissociated aortic cell suspensions were labeled with antibodies targeting specific cellular markers and analyzed via flow cytometry. Consistent with results from fluorescence microscopy, almost 100% of aortic cells from mT/mG•CreER T is mesenchymal and is mainly activated in VSMCs and fibroblasts in the aorta.
We further explored the proportion of each cell type, from the total aortic cells analyzed, that express eGFP ( Figure II in the online-only Data Supplement). The highest proportion of cells in the aorta were VSMCs, and 40% were eGFP+. This was followed by fibroblasts, of which 25% were eGFP+. Both leukocyte and endothelial cells had minimal expression of eGFP, 2.5% and 0.1% of aortic cells, respectively. These data further confirm that Col1a2-CreER T is mostly activated in aortic VSMCs and fibroblasts.
Confirmation of Functional RelA Depletion in Fibrogenic Mesenchymal Cells of RelA-CKO Mice
Since we observed increased RelA signaling in aortic VSMCs and fibroblasts during Ang II infusion (Figure 1) , we used the 
RelA Depletion in Aortic Fibrogenic Mesenchymal Cells Protects From AAA
To determine the contribution of aortic mesenchymal cell RelA to development of Ang II-induced aortic dilation and AAA formation, RelA-CKO and RelA-WT mice were infused with Ang II for 7 days. Abdominal aortic diameter measurements at baseline demonstrated no differences between the 2 groups (1.04±0.01 versus 1.04±0.01 mm, RelA-WT versus RelA-CKO). Ang II infusion significantly increased the mean abdominal aortic diameter in RelA-WT and in RelA-CKO mice (1.36±0.06 versus 1.17±0.03 mm, RelA-WT versus RelA-CKO; Figure 4A ). This corresponded to a 32±6% change in RelA-WT and a 12±2% change in RelA-CKO (P<0.005; Figure 4B ). Furthermore, RelA-CKO mice were completely protected from Ang II-induced AAAs, whereas there was a 20% incidence of AAA in RelA-WT mice ( Figure 4C and 4D). Because both male and female mice were used in this study, we further explored the role of sex on Ang II-induced changes in aortic diameter. Both male and female RelA-WT mice had similar increases in aortic diameter after Ang II infusion (31.8±8% versus 29.7±3.5%, male versus female), and . n=3 aortas were analyzed in each group. Data are presented as the mean of RelA median fluorescence intensity±SEM. *P<0.05. B, Suprarenal abdominal aortas from RelA-WT and RelA-CKO mice were sectioned and immunostained for RelA, which was detected via AF-568 conjugated secondary antibody. DAPI was used to counterstain nuclei. L indicates aortic lumen. n=3 aortas were analyzed in each group. Images were captured at a ×400 magnification. C, Quantitative reverse transcriptase-polymerase chain reaction analysis for RelA and A20-a RelA-dependent gene-was performed on aortas from RelA-WT and RelA-CKO mice. n=3 to 4 mice in each group were evaluated. Data are presented as mean±SEM. *P<0.05. both sexes of RelA-CKO mice had similar decreases in aortic diameter (12.5±4% versus 11.4±3%, male versus female). These data are shown separately for each sex in Figure V in the online-only Data Supplement.
RelA Depletion in Fibrogenic Mesenchymal Cells Diminishes Aortic Inflammation and Expansion
Because RelA is an essential transcriptional activator of inflammatory cytokines IL-6 and IL-1β that have been demonstrated to play a causal role in the development of AAA, we assessed whether these cytokines were affected by RelA depletion. In aortas from RelA-CKO mice infused with Ang II, there was ≈68% decrease in the expression of RelA, IL-6, and IL-1β transcripts ( Figure 5A ). This suggested that a decrease in inflammatory cytokine expression may be one mechanism by which RelA depletion protected from Ang II-induced AAAs. Immunostaining for IL-6 further indicated IL-6 accumulation in the media and adventitia of RelA-WT but not in RelA-CKO aortas ( Figure 5B ). Because IL-6 and IL-1β are potent inducers of the chemokine MCP-1 that promotes monocyte/macrophage accumulation in the aortic wall, MCP-1 immunofluorescence was also performed. Immunofluorescence staining demonstrated significant MCP-1 in the adventitia of RelA-WT but almost a complete absence in RelA-CKO aortas ( Figure 5B) . Similarly, CD68+ monocyte/macrophages were abundant in RelA-WT aortas but significantly diminished in RelA-CKO, indicating that the reduction in chemotactic cytokine production from depletion of RelA was sufficient to reduce monocyte/macrophage recruitment ( Figure 5C ). Ang II-induced changes in the aortic wall included medial dissections and adventitial expansion. Morphometric analysis of RelA-WT and RelA-CKO aortas demonstrated that RelA-CKO aortas were protected from aortic dissections and adventitial hematomas ( Figure IVA in the online-only Data Supplement). Furthermore, after excluding aneurysmal samples in RelA-WT group, we found that RelA-CKO aortas still had significantly less adventitial expansion ( Figure 5D ; Table) . These results suggest that depletion of mesenchymal-restricted cellular RelA decreased aortic cytokine production, monocyte/macrophage accumulation, and limited adventitial expansion.
RelA Depletion Decreases Recruitment of Inflammatory Monocytes Without Affecting Blood Pressure
A hallmark of aortic inflammation is the recruitment of CCR2 (C-C motif chemokine receptor 2)+ monocytes. In mice, ≤60% of the circulating monocytes belong to Ly6C hi and referred to as the nonclassical subset, accumulate in low numbers while patrolling the vasculature for injury. 27, 28 In the absence of the MCP-1 receptor, CCR2, Ly6C hi monocytes fail to migrate to the site of injury, reducing monocyte-induced inflammation, injury, and fibrosis. 3, [30] [31] [32] [33] Because Ly6C hi monocytes are important mediators of aortic inflammation and AAA, we asked whether their abundance was affected by aortic-RelA depletion. Using a flow cytometric analysis for monocyte identification, 34 hi monocytes in RelA-CKO aortas was similar to those observed in sham-infused mice. This suggests that activation of RelA in fibrogenic mesenchymal cells plays a critical role in the recruitment of the inflammatory subset of monocytes. We observed that RelA-WT and RelA-CKO mice, having comparable body weights at baseline, had similar increases in systolic blood pressure and heart rate during the 7 days of Ang II infusion (Table) . Although there was a trend for slightly higher systolic blood pressure in the RelA-CKO mice, this was not statistically significant.
Discussion
Vascular inflammation-a coordinated response involving activating stromal cells that trigger cytokine and chemokine secretion and leukocyte recruitment-is an important contributor to the pathogenesis of AAA. 6 Although the pathogenesis of AAA remains unknown, various animal models have provided insights into the underlying mechanisms and have implicated cytokines IL-6, IL-1β, and the MCP-1 chemokine receptor CCR2 in its pathogenesis. 3, 18, 31 Furthermore, deficiency of AT1aR (Ang II type 1a receptor), 35 pattern recognition receptor TLR4 (Toll-like receptor 4), and the adaptor protein MyD88 36 confers protection from AAA, suggesting that the downstream proinflammatory transcription factor NF-κB/RelA is integral to the development of AAA. In the Ang II model of AAA, it has been observed by our group and others that adventitial proliferation and inflammation precedes loss of vascular integrity and aortic dilation. Proliferating residential adventitial fibroblasts interact with infiltrating monocytes to promote cytokine amplification loops leading to additional inflammation and ECM destruction. 3, 37 In this study, we sought to determine the role of aortic mesenchymal cells that are responsive to Ang II-induced signaling that leads to the development of vascular inflammation and AAA formation.
In this study, we considered the subpopulation of fibroblasts, specialized myofibroblasts, and Col1A-expressing synthetic VSMCs that play predominant roles in fibrosis and aortic ECM formation/remodeling 38, 39 as fibrogenic mesenchymal cells. Although these cells have distinct phenotypes and roles in vascular physiology, they share the common phenotype of Col1A expression and play an important role in Ang II-induced fibrosis and remodeling. Our studies indicate the central role of NF-κB in these fibrogenic mesenchymal cells as an upstream controller of vascular inflammation, cytokine production, and leukocyte infiltration. Our data indicate that Ang II induces RelA activation and IL-6 production in both the adventitial and medial layers of the abdominal aorta. That the mesenchymal lineage is an important component of IL-6 secretion was indicated in our previous studies where IL-6 secretion predominantly originated from mesenchymal and MCP-1 (monocyte chemoattractant protein-1) in suprarenal aortic cross-sections from RelA-WT and RelA-CKO mice infused with Ang II. IL-6 was detected using AF-568-conjugated secondary antibody, and MCP-1 was detected using AF-488 secondary antibody. n=5 to 7 abdominal aortas from each group were evaluated. Representative images from each group are shown. L indicates aortic lumen. Images were captured at a ×400 magnification. C, Immunofluorescence detection of CD68 monocyte/macrophages in suprarenal aortic cross-sections from RelA-WT and RelA-CKO mice infused with Ang II. CD68 was detected using AF-568-conjugated secondary antibody. Representative images from n=5 to 7 aortas from each group are shown. Images were captured at a ×400 magnification. Bottom, relative fluorescence intensity of CD68 staining was quantified using Image J, presented as mean±SEM (n=5-7 from each group). *P<0.05. D, Hematoxylin and eosin (H&E) staining of abdominal aortas from RelA-WT and RelA-CKO mice infused with Ang II. n=5 to 7 abdominal aortas were evaluated in each group. Difference in adventitial thickness (black lines) was observed between the 2 groups. Adventitial area was quantified using Image J software, and is presented as mean±SEM. Images were captured at a ×400 magnification. *P<0.05. cells in the adventitia. 21 In addition to the upregulation of IL-6 mRNA in the aortic wall, we also observed a significant increase in IL-1β and IL-33 transcripts during Ang II infusion, further confirming the functional activation of RelA signaling. The essential role of IL-6 and IL-1β in the development of Ang II-induced AAA has previously been determined, 3, 18 but the significance of IL-33-a cytokine dependent on RelA but also a modifier of RelA signaling-remains to be explored.
To generate mesenchymal cell-derived RelA-deficient animals, we used the Col1a2-CreER T mouse in which the CreER T recombinase, driven by the Col1a2 promoter, is activated in cells of the mesenchymal lineage, 22, 23 including fibroblasts of the dermis, vasculature, intestines, and membranous ossifications of the skull. 40 Consistent with these publications, tamoxifen administration to Col1a2-CreER T •mT/mG Cre-reporter mice demonstrated recombination not only in aortic adventitial fibroblasts but also in aortic VSMCs. Because RelA activation was observed in both medial VSMCs and adventitial fibroblasts, we decided to use this mouse for investigating the role of RelA in this Col1a2-expressing fibrogenic mesenchymal population in AAA. Although it would be of great interest to explore the relative role of fibroblast versus VSMC RelA in the pathogenesis of AAA, currently there is no well-documented, tightly regulated, and rapidly inducible fibroblastspecific Cre transgenic mouse available. As an example, it has been demonstrated that FSP1 (fibroblast-specific protein 1) promoter-driven Cre is also activated in leukocytes, VSMCs, and endothelial cells in the injured myocardium. 41 A recent study suggests that FSP1-Cre-mediated deletion of AT1aR during Ang II infusion protects from medial thickening of the ascending aorta, but the group did not comment on the effect in the abdominal region which is prone to AAA or exclude the possibility that the effect could be because of loss of leukocyte-AT1aR. 42 The mesenchymal cell-restricted RelA-CKO mice were surprisingly resistant to Ang II-induced aortic dilation and AAA formation, despite a statistically insignificant trend toward higher systolic blood pressure in the RelA-CKO mice. This finding argues even more strongly that the decrease in AAA was related to the decrease in aortic cytokine production and monocyte/macrophage recruitment. In this model, adventitial expansion occurs because of both fibroblast proliferation and circulating monocyte recruitment. Using flow cytometry, we demonstrated that RelA-CKO mice had decreased accumulation of the inflammatory CD11b+•F4/80 lo •Ly6C hi monocyte subset during Ang II infusion. Independent investigations have shown that the decrease in circulating monocyte levels with CCR2 deficiency inhibits AAA formation. 3, 31 We interpreted this to mean that fibroblast and VSMC RelA is important in Ang II-induced aortic cytokine production and monocyte recruitment that is necessary for AAA. The role of endothelial NF-κB signaling has also been demonstrated to be vital because transgenic overexpression of dominant-negative IκBα in endothelial cells protects hyperlipidemic mice from AAA. 43 Authors of that study speculated that endothelial NF-κB signaling likely promotes leukocyte-endothelial interaction in the vasa vasorum leading to leukocyte extravasation into the adventitia, promoting vascular remodeling and aortic expansion. 43 Interpreted together with our data, we suggest that coordinate interaction of endothelial cell-mesenchymal NF-κB signaling pathways are required for formation of Ang II-induced aneurysms and dissections.
Our work places RelA signaling in fibrogenic mesenchymal cells as an important upstream event in Ang II-induced AAAs and dissections. In addition to expressing chemokines, cytokines, and adhesion factors, fibrogenic mesenchymal cells secrete and remodel the ECM through Col1A expression, fibronectin production, and matrix metalloproteinase expression. [44] [45] [46] [47] Currently, the field views ECM remodeling/fibrosis and vascular inflammation as largely distinct processes; however, several lines of evidence suggest that inflammation and ECM remodeling are closely intertwined. ECM remodeling has significant effects on inflammation through modification of intercellular adhesion molecules, forming a basement membrane permissive for leukocyte transmigration 14 and release of bioactive and chemotactic molecules. One such protein is the matrix metalloproteinase 2-dependent production of the NH terminal fragment from the α1 procollagen of type I collagen, which has IL-8-like chemotactic activity. 48 Conversely, IL-6 and MCP-1 cytokines produced in response to Ang II via RelA signaling mediate fibroblast proliferation 20 and ECM production. 49 Whether these actions are mediated by distinct mesenchymal subpopulations will require further study. Our findings provide a unifying mechanistic link for the potent effects of Ang II on vascular remodeling and activation of cytokine-dependent inflammation.
In summary, this study delineates a critical role of Col1a2-expressing fibrogenic mesenchymal cells in the development of Ang II-induced vascular inflammation and AAA. Our studies utilizing the deletion of RelA point to the central role of this transcription factor in production of activating cytokines and monocyte recruitment. The key finding of this study that RelA is required for Ang II-induced AAA formation provides impetus to further study how RelA signaling affects the phenotype and secretome of fibrogenic vascular mesenchymal cells. These studies will be foundational to understand some of the proximal steps in aortic inflammation and repair.
